Sherwin-Williams (NYSE:SHW – Get Free Report) had its target price upped by investment analysts at KeyCorp from $400.00 to $410.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has an “overweight” rating on the specialty chemicals company’s stock. KeyCorp’s price objective would indicate a potential upside of 19.55% from the company’s current price.
SHW has been the topic of several other reports. Citigroup lowered their target price on Sherwin-Williams from $390.00 to $370.00 and set a “buy” rating on the stock in a research report on Thursday, April 25th. JPMorgan Chase & Co. lowered their price target on Sherwin-Williams from $317.00 to $315.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 24th. Robert W. Baird lifted their price target on Sherwin-Williams from $300.00 to $310.00 and gave the company a “neutral” rating in a research report on Wednesday, April 24th. Mizuho lowered their price target on Sherwin-Williams from $340.00 to $334.00 and set a “buy” rating on the stock in a research report on Wednesday, April 24th. Finally, Evercore ISI lifted their price target on Sherwin-Williams from $360.00 to $365.00 and gave the company an “outperform” rating in a research report on Tuesday, May 14th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $355.00.
Read Our Latest Research Report on SHW
Sherwin-Williams Stock Up 3.3 %
Sherwin-Williams (NYSE:SHW – Get Free Report) last posted its earnings results on Tuesday, July 23rd. The specialty chemicals company reported $3.70 EPS for the quarter, beating the consensus estimate of $3.51 by $0.19. Sherwin-Williams had a return on equity of 75.58% and a net margin of 10.92%. The firm had revenue of $6.27 billion for the quarter, compared to analysts’ expectations of $6.33 billion. During the same period last year, the firm earned $3.29 EPS. The firm’s revenue was up .5% compared to the same quarter last year. As a group, research analysts predict that Sherwin-Williams will post 11.38 earnings per share for the current year.
Institutional Trading of Sherwin-Williams
Hedge funds and other institutional investors have recently modified their holdings of the business. AIA Group Ltd boosted its position in shares of Sherwin-Williams by 20.8% in the fourth quarter. AIA Group Ltd now owns 16,312 shares of the specialty chemicals company’s stock worth $5,088,000 after buying an additional 2,810 shares during the period. Simplicity Solutions LLC raised its holdings in shares of Sherwin-Williams by 182.2% during the fourth quarter. Simplicity Solutions LLC now owns 10,700 shares of the specialty chemicals company’s stock worth $3,337,000 after acquiring an additional 6,909 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of Sherwin-Williams by 5.7% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 261,178 shares of the specialty chemicals company’s stock worth $77,510,000 after acquiring an additional 13,984 shares in the last quarter. Waterloo Capital L.P. purchased a new stake in shares of Sherwin-Williams during the fourth quarter worth $360,000. Finally, Trust Point Inc. purchased a new stake in shares of Sherwin-Williams during the fourth quarter worth $403,000. Institutional investors and hedge funds own 77.67% of the company’s stock.
About Sherwin-Williams
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
See Also
- Five stocks we like better than Sherwin-Williams
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- How to Read Stock Charts for Beginners
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- Ride Out The Recession With These Dividend Kings
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.